Cost-Effectiveness Analysis of Nirsevimab for the Prevention of Respiratory Syncytial Virus among Italian Infants.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness Analysis of Nirsevimab for the Prevention of Respiratory Syncytial Virus among Italian Infants.
Authors: Bini C; Centre for Economics and International Studies-Economic Evaluation and Health Technology Assessment, Faculty of Economics, University of Rome 'Tor Vergata', via Columbia 2, 00133, Rome, Italy. chiara.bini@uniroma2.it., Marcellusi A; Department of Pharmaceutical Sciences-DISFARM, University of Milan, via G. Colombo, 71, 20133, Milan, Italy., Cazzato D; Centre for Economics and International Studies-Economic Evaluation and Health Technology Assessment, Faculty of Economics, University of Rome 'Tor Vergata', via Columbia 2, 00133, Rome, Italy., Muzii B; Sanofi, Rome, Italy., Soudani S; Sanofi, Lyon, France., Bozzola E; IRCCS Bambino Gesù Children Hospital, Rome, Italy., Midulla F; Department of Maternal Science, Paediatric Emergency Service, Sapienza University of Rome, Rome, Italy., Baraldi E; Department of Woman's and Child's Health, University Hospital of Padova, Padua, Italy., Bonanni P; Department of Health Sciences, University of Florence, 50134, Florence, Italy., Boccalini S; Department of Health Sciences, University of Florence, 50134, Florence, Italy., Orfeo L; Neonatal Intensive Care Unit, 'Isola Tiberina Hospital-Gemelli Isola', 00186, Rome, Italy.
Source: Clinical drug investigation [Clin Drug Investig] 2025 Jun; Vol. 45 (6), pp. 347-361. Date of Electronic Publication: 2025 May 03.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1918
DOI:10.1007/s40261-025-01437-8